Growth/Differentiation Factor 8 (Myostatin or GDF-8) - Pipeline Review, H1 2016; New Report Launched
Growth/Differentiation Factor 8 (Myostatin or GDF-8) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed by Companies. The report GrowthDifferentiation Factor 8 – Pipeline Review, H1 2016, outlays comprehensive information on the Growth/Differentiation Factor 8 (Myostatin or GDF-8) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.
View full press release